Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Wuchner

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Journal of Pharmaceutical Sciences|June 2, 2021
Polysorbate Degradation and Particle Formation in a High Concentration mAb: Formulation Strategies to Minimize Effect of Enzymatic Polysorbate DegradationIan Roy, Ashaben Patel, Vineet Kumar, et al.
Journal of Pharmaceutical Sciences|March 18, 2017
Trends on Analytical Characterization of Polysorbates and Their Degradation Products in Biopharmaceutical FormulationsAriadna Martos, Wendelin Koch, Wim Jiskoot, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 26, 2024
Challenges in the analysis of pharmaceutical lentiviral vector products by orthogonal and complementary physical (nano)particle characterization techniquesDaniela Stadler, Constanze Helbig, Klaus Wuchner, et al.
Journal of Pharmaceutical Sciences|October 14, 2019
Novel High-Throughput Assay for Polysorbate Quantification in Biopharmaceutical Products by Using the Fluorescent Dye DiIAriadna Martos, Michelle Berger, Wendelin Kranz, et al.
Journal of Pharmaceutical Sciences|October 12, 2022
Surface-Induced Protein Aggregation and Particle Formation in Biologics: Current Understanding of Mechanisms, Detection and Mitigation StrategiesMarie R G Kopp, Fulvio Grigolato, Dominik Zürcher, et al.
Journal of Pharmaceutical Sciences|October 16, 2019
What Makes Polysorbate Functional? Impact of Polysorbate 80 Grade and Quality on IgG Stability During Mechanical StressAdam Dariusz Grabarek, Ula Bozic, Jannik Rousel, et al.
Journal of Pharmaceutical Sciences|December 17, 2021
Particles in Biopharmaceutical Formulations, Part 2: An Update on Analytical Techniques and Applications for Therapeutic Proteins, Viruses, Vaccines and CellsAlexandra Roesch, Sarah Zölls, Daniela Stadler, et al.
PDA Journal of Pharmaceutical Science and Technology|November 16, 2021
A Multicompany Survey Study for Helium Leak Container Closure Integrity TestRoman Mathaes, Klaus Wuchner, David Riesop, et al.
Journal of Pharmaceutical Sciences|May 24, 2026
Reply to comment on "Industry guidance on container closure integrity strategies for difficult-to-test parenteral products (DTPs)"Klaus Wuchner, David Riesop, Carine Huon, et al.
PDA Journal of Pharmaceutical Science and Technology|April 20, 2016
A Biopharmaceutical Industry Perspective on the Control of Visible Particles in Biotechnology-Derived Injectable Drug ProductsSerge Mathonet, Hanns-Christian Mahler, Stefan T Esswein, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Journal of Pharmaceutical Sciences|June 2, 2021
Polysorbate Degradation and Particle Formation in a High Concentration mAb: Formulation Strategies to Minimize Effect of Enzymatic Polysorbate DegradationIan Roy, Ashaben Patel, Vineet Kumar, et al.
Journal of Pharmaceutical Sciences|March 18, 2017
Trends on Analytical Characterization of Polysorbates and Their Degradation Products in Biopharmaceutical FormulationsAriadna Martos, Wendelin Koch, Wim Jiskoot, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 26, 2024
Challenges in the analysis of pharmaceutical lentiviral vector products by orthogonal and complementary physical (nano)particle characterization techniquesDaniela Stadler, Constanze Helbig, Klaus Wuchner, et al.
Journal of Pharmaceutical Sciences|October 14, 2019
Novel High-Throughput Assay for Polysorbate Quantification in Biopharmaceutical Products by Using the Fluorescent Dye DiIAriadna Martos, Michelle Berger, Wendelin Kranz, et al.
Journal of Pharmaceutical Sciences|October 12, 2022
Surface-Induced Protein Aggregation and Particle Formation in Biologics: Current Understanding of Mechanisms, Detection and Mitigation StrategiesMarie R G Kopp, Fulvio Grigolato, Dominik Zürcher, et al.
Journal of Pharmaceutical Sciences|October 16, 2019
What Makes Polysorbate Functional? Impact of Polysorbate 80 Grade and Quality on IgG Stability During Mechanical StressAdam Dariusz Grabarek, Ula Bozic, Jannik Rousel, et al.
Journal of Pharmaceutical Sciences|December 17, 2021
Particles in Biopharmaceutical Formulations, Part 2: An Update on Analytical Techniques and Applications for Therapeutic Proteins, Viruses, Vaccines and CellsAlexandra Roesch, Sarah Zölls, Daniela Stadler, et al.
PDA Journal of Pharmaceutical Science and Technology|November 16, 2021
A Multicompany Survey Study for Helium Leak Container Closure Integrity TestRoman Mathaes, Klaus Wuchner, David Riesop, et al.
Journal of Pharmaceutical Sciences|May 24, 2026
Reply to comment on "Industry guidance on container closure integrity strategies for difficult-to-test parenteral products (DTPs)"Klaus Wuchner, David Riesop, Carine Huon, et al.
PDA Journal of Pharmaceutical Science and Technology|April 20, 2016
A Biopharmaceutical Industry Perspective on the Control of Visible Particles in Biotechnology-Derived Injectable Drug ProductsSerge Mathonet, Hanns-Christian Mahler, Stefan T Esswein, et al.
Pageof 4